Recent Insider Transactions - Viridian Therapeutics (NASDAQ: VRDN)

Company

Name / Role

Date

Type

Price

# Shares

Value

Balance

NASDAQ VRDN Viridian Therapeutics

Ajer Jeffrey Robert / director

04/07/2025

Buy

$11.78

42,000

$495K

42,000

NASDAQ VRDN Viridian Therapeutics

Tripuraneni Radhika / officer: Chief Medical Officer

03/10/2025

Buy

$15.58

310,700

$4.841M

310,700

NASDAQ VRDN Viridian Therapeutics

Tripuraneni Radhika / officer: Chief Medical Officer

03/10/2025

Sell

$13.21

40,000

$528K

NASDAQ VRDN Viridian Therapeutics

CAIN CHRISTOPHER W. / director

03/10/2025

Buy

$15.58

42,000

$654K

42,000

NASDAQ VRDN Viridian Therapeutics

Tousignant Jennifer / officer: Chief Legal Officer

03/03/2025

Buy

$14.41

124,072

$1.788M

124,072

NASDAQ VRDN Viridian Therapeutics

Mahoney Stephen F. / director, officer: President and CEO

03/03/2025

Buy

$14.41

440,565

$6.349M

440,565

NASDAQ VRDN Viridian Therapeutics

Beetham Thomas W. / officer: Chief Operating Officer

03/03/2025

Buy

$14.41

225,814

$3.254M

225,814

NASDAQ VRDN Viridian Therapeutics

Harmon Seth / officer: Chief Financial Officer

03/03/2025

Buy

$14.41

150,407

$2.167M

150,407